Private Capital Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
Private Capital Group's NVO Position: Q2 2022 in Review
Private Capital Group reduced its Novo Nordisk (NVO) stake by 22% in Q2 2022, selling an estimated $73.1K and leaving 4,786 shares worth $267K. The position accounts for 0.2% of the portfolio, ranked #91.
Private Capital Group first reported a position in NVO in Q4 2017 and has held it in 19 quarters since. The position peaked at $716K in Q1 2020. 932 funds tracked by Wall St. Rank hold NVO as of Q2 2022.
- Private Capital Group held 4,786 shares of Novo Nordisk worth $267K as of Q2 2022.
- Private Capital Group sold 1,318 Novo Nordisk shares in Q2 2022, an estimated $73.1K.
- Novo Nordisk made up 0.2% of Private Capital Group's portfolio in Q2 2022, its #91 holding.
- Private Capital Group first reported a position in Novo Nordisk in Q4 2017 and has held it in 19 quarters since.
- Private Capital Group's Novo Nordisk position peaked at $716K in Q1 2020.
- 932 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2022.
Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.